A detailed history of Fagan Associates, Inc. transactions in Tilray Brands, Inc. stock. As of the latest transaction made, Fagan Associates, Inc. holds 20,146 shares of TLRY stock, worth $27,197. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,146
Previous 10,146 98.56%
Holding current value
$27,197
Previous $16,000 118.75%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.62 - $2.03 $16,200 - $20,299
10,000 Added 98.56%
20,146 $35,000
Q2 2024

Aug 09, 2024

BUY
$1.62 - $2.85 $16,436 - $28,916
10,146 New
10,146 $16,000

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $825M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Fagan Associates, Inc. Portfolio

Follow Fagan Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fagan Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fagan Associates, Inc. with notifications on news.